{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+draw+for+the+study+participants", "query": { "intervention": "Blood draw for the study participants" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 2449, "total_pages": 245, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+draw+for+the+study+participants&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-30T04:03:31.770Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03316274", "title": "Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Kaposi Sarcoma", "HIV/AIDS", "Immunosuppression" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2018-05-07", "completion_date": "2021-06-30", "has_results": false, "last_update_posted_date": "2024-06-25", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03316274" }, { "nct_id": "NCT02584296", "title": "Physical Activity as Self-Management Approach to Improve Health Outcomes in AML", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Leukemia", "Myeloid", "Monocytic" ], "interventions": [ { "name": "BSMA", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2015-03", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2017-01-06", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584296" }, { "nct_id": "NCT04802759", "title": "A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer" ], "interventions": [ { "name": "Giredestrant", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Ipatasertib", "type": "DRUG" }, { "name": "Inavolisib", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Everolimus", "type": "DRUG" }, { "name": "Samuraciclib", "type": "DRUG" }, { "name": "PH FDC SC", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 316, "start_date": "2021-06-22", "completion_date": "2029-05-30", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 12, "location_summary": "Duarte, California • Irvine, California • San Francisco, California + 9 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04802759" }, { "nct_id": "NCT07625579", "title": "Collaboration for Down Syndrome Progress (CDP)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Down Syndrome", "Chromosome Disorders", "Intellectual and Developmental Disabilities" ], "interventions": [], "intervention_types": [], "sponsor": "RTI International", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1400, "start_date": "2026-05-01", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 15, "location_summary": "Orange, California • Aurora, Colorado • Miami, Florida + 12 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07625579" }, { "nct_id": "NCT06848361", "title": "Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes Mellitus (T2DM)" ], "interventions": [ { "name": "MPowerHub", "type": "DEVICE" }, { "name": "Continuous Glucose Monitor (CGM)", "type": "DEVICE" }, { "name": "Activity Monitor", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ann-Marie Rosland", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2025-04-28", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06848361" }, { "nct_id": "NCT04931342", "title": "A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "Ipatasertib", "type": "DRUG" }, { "name": "Cobimetinib", "type": "DRUG" }, { "name": "Trastuzumab Emtansine", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Giredestrant", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Inavolisib", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Luteinizing Hormone-Releasing Hormone (LHRH) Agonists", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 176, "start_date": "2021-10-07", "completion_date": "2028-05-30", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 8, "location_summary": "San Francisco, California • St Louis, Missouri • Charlotte, North Carolina + 5 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT04931342" }, { "nct_id": "NCT07225270", "title": "Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ovarian Cancer", "Platinum-sensitive Ovarian Cancer", "PSOC" ], "interventions": [ { "name": "Rina-S", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genmab", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 544, "start_date": "2026-04-03", "completion_date": "2030-05", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 5, "location_summary": "Miami, Florida • Sarasota, Florida • Towson, Maryland + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Towson", "state": "Maryland" }, { "city": "Centerville", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07225270" }, { "nct_id": "NCT07842341", "title": "MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertensive Disorders of Pregnancy", "Chronic Hypertension in Pregnancy", "Gestational Hypertension" ], "interventions": [ { "name": "Community Health Worker (CHW)/Social Worker (SW)-led non-medical health related needs (NMHRN) intervention + Clinician-Led Medication Therapy Management (MTM) with remote blood pressure monitoring", "type": "BEHAVIORAL" }, { "name": "Active Comparator (Control group)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Texas Southern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 158, "start_date": "2026-09-09", "completion_date": "2029-12-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07842341" }, { "nct_id": "NCT06335537", "title": "Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Uric Acid Stones" ], "interventions": [ { "name": "Potassium citrate", "type": "DRUG" }, { "name": "Sodium bicarbonate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 100, "start_date": "2025-05-01", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06335537" }, { "nct_id": "NCT05528770", "title": "Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "FCL+BPS", "type": "DEVICE" }, { "name": "FCL", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Marc Breton", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 15, "start_date": "2022-10-20", "completion_date": "2023-01-15", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-09-30T04:03:31.770Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05528770" } ] }